| Security Name | Asset Type |
Shares or Principal Amount |
Market Value |
Percent of Net Assets |
|---|---|---|---|---|
| Capital Group Central Cash Fund | Short Term | 60,108,480 | $6,011,449,123.00 | 4.98% |
| Broadcom, Inc. | Equity | 14,472,248 | $5,008,845,033.00 | 4.15% |
| Taiwan Semiconductor Manufacturing Co., Ltd. | Equity | 62,251,820 | $3,041,211,667.00 | 2.52% |
| Philip Morris International, Inc. | Equity | 17,805,990 | $2,856,080,796.00 | 2.36% |
| Capital Group Central Corporate Bond Fund | Investment Fund | 321,685,020 | $2,734,322,674.00 | 2.26% |
| RTX Corp. | Equity | 12,387,541 | $2,271,875,019.00 | 1.88% |
| British American Tobacco PLC | Equity | 37,995,924 | $2,153,519,577.00 | 1.78% |
| JPMorgan Chase & Co. | Equity | 5,755,140 | $1,854,421,211.00 | 1.54% |
| AbbVie, Inc. | Equity | 8,047,117 | $1,838,685,763.00 | 1.52% |
| Microsoft Corp. | Equity | 3,530,802 | $1,707,566,463.00 | 1.41% |
| AstraZeneca PLC | Equity | 6,985,982 | $1,286,761,237.00 | 1.07% |
| Abbott Laboratories | Equity | 9,628,283 | $1,206,327,577.00 | 1% |
| Exxon Mobil Corp. | Equity | 10,012,276 | $1,204,877,294.00 | 1% |
| Amgen, Inc. | Equity | 3,543,774 | $1,159,912,668.00 | 0.96% |
| Morgan Stanley | Equity | 6,177,820 | $1,096,748,385.00 | 0.91% |